Thanks for that. Richard stated that this FDA hold up will not change the timeline for submission.
The quarterly, I have to agree with Eqz & Bella, I can’t see anything negative there, in fact very happy to see PIQ are presenting at so many conferences this year! They have a lot more data to present now. I think @Eqz covered all the other positives.
I was frustrated about this delay this morning too, quite a few swear words came out. When I read that article posted, it actually really put things into perspective, & it’s not the situation per se, but your attitude in dealing with something that you can’t change that makes all the difference.
It was good PIQ also put the quarterly out today, to give further clarity on the situation as a whole for the company & you can clearly see that research in the US in regards to reimbursement & health economics data has progressed, to be presented at the ADA meeting (Abstracts will be published on May 28 and posters embargoed until the meeting starts on June 25, will be virtual in 2021).
Anyways, I guess we should be thankful it’s not bad news & everyone is in the same boat in biotech land with the FDA as a few others have posted here.
The SP didn’t change too much today, pretty much up & down anyway, so glad some took advantage & bought more today.
GLTAH
PIQ Price at posting:
$1.18 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)